This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1976 Feb;60(2):165-76.

DTIC (NSC-45388) in malignant melanoma: a perspective

PMID: 769969

Review

DTIC (NSC-45388) in malignant melanoma: a perspective

R L Comis. Cancer Treat Rep. 1976 Feb.

. 1976 Feb;60(2):165-76.

Author

PMID: 769969

No abstract available

PubMed Disclaimer

Similar articles

Phase I evaluation of DTIC (NSC-45388) and other studies in malignant melanoma in the Central Oncology Group.
Johnson RO, Metter G, Wilson W, Hill G, Krementz E. Johnson RO, et al. Cancer Treat Rep. 1976 Feb;60(2):183-7. Cancer Treat Rep. 1976. PMID: 769971 Clinical Trial.
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
Carter RD, Krementz ET, Hill GJ 2nd, Metter GE, Fletcher WS, Golomb FM, Grage TB, Minton JP, Sparks FC. Carter RD, et al. Cancer Treat Rep. 1976 May;60(5):601-9. Cancer Treat Rep. 1976. PMID: 991149 Clinical Trial.
Eastern Cooperative Oncology Group studies with DTIC (NSC-45388).
Carbone PP, Costello W. Carbone PP, et al. Cancer Treat Rep. 1976 Feb;60(2):193-8. Cancer Treat Rep. 1976. PMID: 769973 Clinical Trial.
[DTIC in malignant melanoma: a perspective (author's transl)].
Kokoschka EM. Kokoschka EM. Wien Klin Wochenschr. 1978 Dec 22;90(24):870-4. Wien Klin Wochenschr. 1978. PMID: 369152 Review. German.
[Dacarbacine (DTIC) in the therapy of a malignant disease. A review (author's transl)].
Huber H, Grünewald K. Huber H, et al. Wien Klin Wochenschr. 1978 Dec 22;90(24):861-4. Wien Klin Wochenschr. 1978. PMID: 369151 Review. German.

See all similar articles

Cited by

Peripheral DTIC neurotoxicity: a case report.
Amichetti M, Piffer S, Valdagni R, Ambrosini G, Piazza M. Amichetti M, et al. Cancer Chemother Pharmacol. 1987;19(1):87-8. doi: 10.1007/BF00296264. Cancer Chemother Pharmacol. 1987. PMID: 3028665 No abstract available.
A phase II study of alpha-difluoromethylornithine (DFMO) for the treatment of metastatic melanoma.
Meyskens FL, Kingsley EM, Glattke T, Loescher L, Booth A. Meyskens FL, et al. Invest New Drugs. 1986;4(3):257-62. doi: 10.1007/BF00179593. Invest New Drugs. 1986. PMID: 3102397
High-dose cisplatin in disseminated melanoma: a comparison of two schedules.
Mortimer JE, Schulman S, MacDonald JS, Kopecky K, Goodman G. Mortimer JE, et al. Cancer Chemother Pharmacol. 1990;25(5):373-6. doi: 10.1007/BF00686241. Cancer Chemother Pharmacol. 1990. PMID: 2306798
Systemic therapy of non-resectable metastatic melanoma.
Orouji A, Goerdt S, Utikal J. Orouji A, et al. Cancers (Basel). 2010 May 26;2(2):955-69. doi: 10.3390/cancers2020955. Cancers (Basel). 2010. PMID: 24281101 Free PMC article.
An inverse relationship between the growth rate of human melanoma xenografts and their response to some cytostatic drugs.
Fodstad O, Aass N, Pihl A. Fodstad O, et al. Br J Cancer. 1980 May;41(5):829-31. doi: 10.1038/bjc.1980.149. Br J Cancer. 1980. PMID: 7426308 Free PMC article. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database